NIH gives $129M to 9 companies to boost COVID-19 testing

The National Institutes of Health said Sept. 2 that it is giving $129.3 million to nine companies to scale up manufacturing of COVID-19 tests. 

The contracts are part of the NIH's Rapid Acceleration of Diagnostics, or RADx, program it started in late April to speed the development of COVID-19 tests. 

The money will support developing technologies for COVID-19 tests, such as portable point-of-care tests that can give immediate results. The new technologies will significantly increase the number, type and availability of tests by millions per week this fall, the NIH said. 

The nine companies receiving the money are: 

  • MatMaCorp in Lincoln, Neb. 
  • Maxim Biomedical in Rockville, Md.
  • MicroGEM International in Charlottesville, Va. 
  • Aegis Sciences in Nashville, Tenn. 
  • Broad Institute in Cambridge, Mass. 
  • Ceres Nanoscience in Manassas, Va. 
  • Illumina in San Diego 
  • PathGroup in Nashville, Tenn. 
  • Sonic Healthcare USA in Austin, Texas 

Read the NIH's full news release here

More articles on supply chain:
Amazon's delivery drones cleared for takeoff
US awards Abbott $760M contract for rapid COVID-19 tests
Medical device recalls rise 31% in Q2

 

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Whitepapers

Featured Webinars